MX2009012506A - Composiciones, sintesis, y metodos para utilizar agentes antipsicoticos atipicos basados en quinolinona. - Google Patents
Composiciones, sintesis, y metodos para utilizar agentes antipsicoticos atipicos basados en quinolinona.Info
- Publication number
- MX2009012506A MX2009012506A MX2009012506A MX2009012506A MX2009012506A MX 2009012506 A MX2009012506 A MX 2009012506A MX 2009012506 A MX2009012506 A MX 2009012506A MX 2009012506 A MX2009012506 A MX 2009012506A MX 2009012506 A MX2009012506 A MX 2009012506A
- Authority
- MX
- Mexico
- Prior art keywords
- synthesis
- compositions
- methods
- atypical antipsychotic
- antipsychotic agents
- Prior art date
Links
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003693 atypical antipsychotic agent Substances 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229930185107 quinolinone Natural products 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
La presente invención proporciona derivados novedosos de quinolinona que pueden utilizarse ventajosamente para tratar la esquizofrenia y psicosis relacionadas tales como desorden bipolar maniaco agudo, desorden autista, y depresión.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93926207P | 2007-05-21 | 2007-05-21 | |
PCT/US2008/064433 WO2008144764A1 (en) | 2007-05-21 | 2008-05-21 | Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009012506A true MX2009012506A (es) | 2009-12-09 |
Family
ID=40072982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009012506A MX2009012506A (es) | 2007-05-21 | 2008-05-21 | Composiciones, sintesis, y metodos para utilizar agentes antipsicoticos atipicos basados en quinolinona. |
Country Status (13)
Country | Link |
---|---|
US (1) | US8247420B2 (es) |
EP (1) | EP2162135A4 (es) |
JP (1) | JP5466147B2 (es) |
CN (1) | CN101754761B (es) |
AU (1) | AU2008254585B2 (es) |
BR (1) | BRPI0811844A2 (es) |
CA (1) | CA2688784A1 (es) |
IL (1) | IL202003A (es) |
MX (1) | MX2009012506A (es) |
NZ (1) | NZ582124A (es) |
RU (1) | RU2497819C2 (es) |
WO (1) | WO2008144764A1 (es) |
ZA (1) | ZA200908753B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE031053T2 (en) * | 2009-02-26 | 2017-06-28 | Reviva Pharmaceuticals Inc | Preparations, synthesis and methods of application of arylpiperazine derivatives |
EP4124616A1 (en) | 2009-06-25 | 2023-02-01 | Alkermes Pharma Ireland Limited | Heterocyclic compounds for the treatment of neurological and psychological disorders |
PL395469A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Pochodne indoloamin do leczenia chorób osrodkowego ukladu nerwowego |
WO2016115039A1 (en) | 2015-01-12 | 2016-07-21 | Reviva Pharmaceuticals Inc. | Methods for treating pulmonary hypertension |
CN106749219A (zh) * | 2015-11-20 | 2017-05-31 | 江苏恩华药业股份有限公司 | 一种内酰胺类衍生物及其应用 |
RU2667954C2 (ru) * | 2016-03-04 | 2018-09-25 | Общество С Ограниченной Ответственностью "Валентек" | Фармацевтическая композиция для лечения функциональных психических расстройств |
KR102444803B1 (ko) * | 2017-05-04 | 2022-09-19 | 익스시바 게엠베하 | 신규 조성물, 조합 및 그의 방법을 갖는 표적 약물 구제 |
EP3642184A1 (en) * | 2017-06-22 | 2020-04-29 | Curadev Pharma Limited | Small molecule modulators of human sting |
BR112019027127A2 (pt) | 2017-06-22 | 2020-07-07 | Curadev Pharma Limited | moduladores de sting humano de molécula pequena |
EP3761983A1 (en) | 2018-03-05 | 2021-01-13 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
CN115784983A (zh) * | 2022-12-05 | 2023-03-14 | 井冈山大学 | 6-胺烷氧基-3,4-二氢喹啉酮衍生物及制备方法和应用 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
JPS5649361A (en) * | 1979-09-28 | 1981-05-02 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
JPS5649364A (en) * | 1979-09-28 | 1981-05-02 | Otsuka Pharmaceut Co Ltd | Carbostyril derivative |
DE3442570A1 (de) * | 1984-11-22 | 1986-05-22 | Hoechst Ag, 6230 Frankfurt | Neue substituierte phenylpiperazinderivate, verfahren zu deren herstellung und die verwendung substituierter phenylpiperazinderivate als aggressionshemmer fuer tiere |
DE3815221C2 (de) * | 1988-05-04 | 1995-06-29 | Gradinger F Hermes Pharma | Verwendung einer Retinol- und/oder Retinsäureester enthaltenden pharmazeutischen Zubereitung zur Inhalation zur Einwirkung auf die Schleimhäute des Tracheo-Bronchialtraktes einschließlich der Lungenalveolen |
JP2608788B2 (ja) * | 1988-10-31 | 1997-05-14 | 大塚製薬 株式会社 | 精神分裂病治療剤 |
US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
US5776959A (en) * | 1995-06-05 | 1998-07-07 | Washington University | Anticonvulsant and anxiolytic lactam and thiolactam derivatives |
EP0900792B1 (en) | 1997-09-02 | 2003-10-29 | Duphar International Research B.V | Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists |
US6174882B1 (en) * | 1998-11-23 | 2001-01-16 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
US6432985B2 (en) * | 2000-04-25 | 2002-08-13 | Hoffmann-La Roche Inc. | Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists |
US6521623B1 (en) * | 2000-09-19 | 2003-02-18 | Boehringer Ingelheim Pharma Kg | N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
SE0200301D0 (sv) | 2002-02-01 | 2002-02-01 | Axon Biochemicals Bv | Thio-carbostyril derivative |
MXPA04009435A (es) * | 2002-03-29 | 2005-01-25 | Janssen Pharmaceutica Nv | Derivados de quinolina y quinolinona radiomarcados y su uso como ligandos de receptor de glutamato metabotropico. |
TWI312781B (en) * | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
UA77526C2 (en) * | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
KR20050057404A (ko) * | 2002-09-17 | 2005-06-16 | 워너-램버트 캄파니 엘엘씨 | 정신분열증 치료용 헤테로환 치환된 피페라진 |
DE60302139T3 (de) | 2003-01-09 | 2011-02-24 | Otsuka Pharmaceutical Co., Ltd. | Verfahren zur herstellung von aripiprazole |
TWI289141B (en) * | 2003-03-11 | 2007-11-01 | Hoffmann La Roche F. Ag. | Quinolinone derivatives and uses thereof |
CA2428237C (en) | 2003-05-08 | 2010-07-20 | Delmar Chemicals Inc. | Process for the preparation of carbostyril derivatives |
EP1626721B1 (en) * | 2003-05-23 | 2016-12-07 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives and mood stabilizers for treating mood disorders |
US7160888B2 (en) * | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
WO2006030446A1 (en) | 2004-09-13 | 2006-03-23 | Matrix Laboratories Ltd | Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts |
CA2584789C (en) | 2004-10-08 | 2010-11-23 | Suven Life Sciences Limited | Method for the preparation of aripiprazole, and corresponding intermediates and their preparation |
-
2008
- 2008-05-21 EP EP20080756096 patent/EP2162135A4/en not_active Withdrawn
- 2008-05-21 AU AU2008254585A patent/AU2008254585B2/en not_active Ceased
- 2008-05-21 BR BRPI0811844-2A2A patent/BRPI0811844A2/pt not_active IP Right Cessation
- 2008-05-21 WO PCT/US2008/064433 patent/WO2008144764A1/en active Application Filing
- 2008-05-21 CA CA2688784A patent/CA2688784A1/en not_active Abandoned
- 2008-05-21 JP JP2010509539A patent/JP5466147B2/ja not_active Expired - Fee Related
- 2008-05-21 US US12/124,985 patent/US8247420B2/en active Active
- 2008-05-21 NZ NZ582124A patent/NZ582124A/en not_active IP Right Cessation
- 2008-05-21 MX MX2009012506A patent/MX2009012506A/es active IP Right Grant
- 2008-05-21 RU RU2009147268/04A patent/RU2497819C2/ru not_active IP Right Cessation
- 2008-05-21 CN CN200880025022.6A patent/CN101754761B/zh not_active Expired - Fee Related
-
2009
- 2009-01-01 ZA ZA200908753A patent/ZA200908753B/xx unknown
- 2009-11-09 IL IL202003A patent/IL202003A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ582124A (en) | 2012-07-27 |
BRPI0811844A2 (pt) | 2014-11-18 |
EP2162135A4 (en) | 2012-02-22 |
EP2162135A1 (en) | 2010-03-17 |
AU2008254585A1 (en) | 2008-11-27 |
CA2688784A1 (en) | 2008-11-27 |
CN101754761B (zh) | 2014-06-18 |
IL202003A0 (en) | 2010-06-16 |
US8247420B2 (en) | 2012-08-21 |
CN101754761A (zh) | 2010-06-23 |
ZA200908753B (en) | 2010-07-28 |
RU2497819C2 (ru) | 2013-11-10 |
WO2008144764A1 (en) | 2008-11-27 |
IL202003A (en) | 2013-11-28 |
JP2010528042A (ja) | 2010-08-19 |
AU2008254585B2 (en) | 2013-09-26 |
RU2009147268A (ru) | 2011-06-27 |
JP5466147B2 (ja) | 2014-04-09 |
US20080293736A1 (en) | 2008-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009012506A (es) | Composiciones, sintesis, y metodos para utilizar agentes antipsicoticos atipicos basados en quinolinona. | |
MY161473A (en) | Compositions, synthesis, and methods of utilizing arylpiperazine derivatives | |
EA201071234A1 (ru) | Производные изохинолинона в качестве nk3 антагонистов | |
MX2011009568A (es) | Inhibidores de la rho cinasa. | |
JO2788B1 (en) | Amido phenoxyendazole compounds beneficial as C-MET inhibitors | |
MY153915A (en) | Organic compounds | |
MX353257B (es) | Compuestos heterociclicos utiles como inhibidores de proteina cinasa-1 dependiente de 3-fosfoinositido (pdk1). | |
MX354402B (es) | Inhibidores de molecula pequeña del dominio de homologia de pleckstrin y metodos para usar los mismos. | |
MX2011001679A (es) | Derivados de flavina. | |
MX2010003366A (es) | Derivados de piperidina y piperazina para el tratamiento de tumores. | |
MY152749A (en) | Pyrazole and fused pyrazole glucokinase activators | |
ATE548374T1 (de) | 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren | |
MY150542A (en) | Cmet inhibitors | |
TW201713640A (en) | Bruton's tyrosine kinase inhibitors | |
AU2011278832A8 (en) | Novel fused heterocyclic derivatives useful as c-Met tyrosine kinase inhibitors | |
UA102251C2 (ru) | Производные аминодигидротиазина как ингибиторы васе для лечения болезни альцгеймера | |
WO2009117676A3 (en) | Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase | |
MX2012002366A (es) | Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina. | |
MX2010003685A (es) | Analogos de quinolona y metodos relacionados con los mismos. | |
NI200900151A (es) | Nuevo procedimiento de síntesis de la agomelatina. | |
MX2010003365A (es) | Derivados de tiazol para el tratamiento de cancer. | |
GB2466912A (en) | Compositions and methods for treating lysosomal disorders | |
MY173526A (en) | Novel anti-?5?1 antibodies and uses thereof | |
NI200900153A (es) | Nuevo procedimiento de síntesis de la agomelatina. | |
MX2009013515A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |